DaQuan Wang Selected Research

validamycins

1/2022

Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

DaQuan Wang Research Topics

Disease

4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
1	Carcinogenesis 01/2022
1	Diabetes Mellitus 01/2022
1	Neoplasms (Cancer) 01/2022
1	Disease Progression 01/2022
1	Leukopenia 01/2022
1	Lung Neoplasms (Lung Cancer) 11/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2022
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Acarbose FDA LinkGeneric 01/2022
1	validamycinsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	FructoseIBA 01/2022
1	Mannose (D-Mannose)IBA 01/2022
1	nimotuzumabIBA 11/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Etoposide (VP 16)FDA LinkGeneric 10/2021

Therapy/Procedure

3	Radiotherapy 01/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Chemoradiotherapy 01/2022 - 01/2022
1	Therapeutics 11/2021
1	Cranial Irradiation 10/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021